Uma Lakshmipathy, PhD - Thermo Fisher Scientific - Director

Uma Lakshmipathy

PhD

Thermo Fisher Scientific

Director

Carlsbad, CA | United States

Main Specialties: Biology

Additional Specialties: Pluripotent Stem Cells, Adult Stem Cells, Cell Biology, transcriptome analysis


Top Author

Uma Lakshmipathy, PhD - Thermo Fisher Scientific - Director

Uma Lakshmipathy

PhD

Introduction

Primary Affiliation: Thermo Fisher Scientific - Carlsbad, CA , United States

Specialties:

Additional Specialties:


View Uma Lakshmipathy’s Resume / CV

Metrics

Number of Publications

30

Publications

Number of Profile Views

396

Profile Views

Number of Article Reads

221

Reads

Number of Citations

565

Citations

Education

Dec 1997
Center for Cellular
Ph.D.
May 1991
Bangalore University
M. Sc.
May 1989
Bangalore University
B. Sc.

Publications

30Publications

221Reads

565PubMed Central Citations

Kinetic Measurement and Real Time Visualization of Somatic Reprogramming.

J Vis Exp 2016 07 30(113). Epub 2016 Jul 30.

Life Sciences Solutions, Thermo Fisher Scientific;

View Article
July 2016
1 Read

Characterizing Pluripotent Stem Cells Using the TaqMan® hPSC Scorecard(TM) Panel.

Methods Mol Biol 2016 ;1307:25-37

Life Sciences Solutions, Thermo Fisher Scientific, 5781 Van Allen Way, Carlsbad, CA, 92008, USA.

View Article
May 2016
2 Reads
5 Citations

Current methods and challenges in the comprehensive characterization of human pluripotent stem cells.

Stem Cell Rev 2015 Apr;11(2):357-72

Cell Biology, Life Sciences Solutions, Thermo Fisher Scientific, 5781 Van Allen Way, Carlsbad, CA, 92008, USA.

View Article
April 2015
1 Read
2 Citations
2.770 Impact Factor

CD44 is a negative cell surface marker for pluripotent stem cell identification during human fibroblast reprogramming.

PLoS One 2014 9;9(1):e85419. Epub 2014 Jan 9.

Cell Biology & Stem Cell Sciences, Life Technologies, Carlsbad, California, United States of America.

View Article
September 2014
11 Reads
10 Citations
3.230 Impact Factor

Advances in genetic modification of pluripotent stem cells.

Biotechnol Adv 2013 Nov 12;31(7):994-1001. Epub 2013 Jul 12.

Primary and Stem Cell Systems, Life Technologies, 5781 Van Allen Way, Carlsbad, CA 92008, USA.

View Article
November 2013
2 Reads
9 Citations
9.020 Impact Factor

Stable transfection using episomal vectors to create modified human embryonic stem cells.

Methods Mol Biol 2013 ;997:263-72

Department of Neurosurgery, UT Health, Houston, TX, USA.

View Article
September 2013
3 Reads
1 Citation

Development and characterization of a clinically compliant xeno-free culture medium in good manufacturing practice for human multipotent mesenchymal stem cells.

Stem Cells Transl Med 2012 Oct 10;1(10):750-8. Epub 2012 Oct 10.

Primary and Stem Cell Systems, Life Technologies, Madison, Wisconsin, USA.

View Article
October 2012
31 Reads
25 Citations
3.600 Impact Factor

Novel live alkaline phosphatase substrate for identification of pluripotent stem cells.

Stem Cell Rev 2012 Sep;8(3):1021-9

Molecular Probes, Life Technologies, 29851 Willow Creek Road, Eugene, OR 97402, USA.

View Article
September 2012
2 Reads
8 Citations
2.770 Impact Factor

Efficient non-viral integration and stable gene expression in multipotent adult progenitor cells.

Stem Cells Int 2011 2;2011:717069. Epub 2011 Oct 2.

Center for Genome Engineering, Gene Therapy Program, Institute of Human Genetics, University of Minnesota, Minneapolis, MN 55455, USA.

View Article
November 2011
1 Read
3 Citations

BacMam-mediated gene delivery into multipotent mesenchymal stromal cells.

Methods Mol Biol 2011 ;698:485-504

Primary and Stem Cell Systems, Life Technologies, Carlsbad, CA, USA.

View Article
July 2011
8 Reads

miRNA in pluripotent stem cells.

Regen Med 2010 Jul;5(4):545-55

WM Keck Center for Collaborative Neuroscience, Rutgers University, Piscataway, NJ 08854, USA.

View Article
July 2010
7 Reads
6 Citations
2.790 Impact Factor

A novel serum-free medium for the expansion of human mesenchymal stem cells.

Stem Cell Res Ther 2010 Apr 2;1(1). Epub 2010 Apr 2.

Primary and Stem Cell Systems, Life Technologies, 501 Charmany Drive, Madison, WI 53719, USA.

View Article
April 2010
6 Reads
45 Citations
3.370 Impact Factor

A simplified culture and polymerase chain reaction identification assay for quality control performance testing of stem cell media products.

Cytotherapy 2009 ;11(6):761-7, 767.e1-2

Life Technologies, Primary and Stem Cell Systems, Frederick, Maryland 21704,USA.

View Article
January 2010
2 Reads
2 Citations
3.290 Impact Factor

Generation of platform human embryonic stem cell lines that allow efficient targeting at a predetermined genomic location.

Stem Cells Dev 2009 Dec;18(10):1459-72

Primary and Stem Cell Systems, Life Technologies Corporation, Carlsbad, California 92008, USA.

View Article
December 2009
7 Reads
9 Citations
3.730 Impact Factor

A single EBV-based vector for stable episomal maintenance and expression of GFP in human embryonic stem cells.

Regen Med 2009 Mar;4(2):239-50

Primary and Stem Cell Systems, Life Technologies, 5781 Van Allen Way, Carlsbad, CA 92008, USA.

View Article
March 2009
2 Reads
1 Citation
2.790 Impact Factor

Differentiating human multipotent mesenchymal stromal cells regulate microRNAs: prediction of microRNA regulation by PDGF during osteogenesis.

Exp Hematol 2008 Oct 26;36(10):1354-1369. Epub 2008 Jul 26.

W. M. Keck Center for Collaborative Neuroscience and Rutgers Stem Cell Research Center, Rutgers University, Piscataway, NJ, USA.

View Article
October 2008
5 Reads
19 Citations
2.480 Impact Factor

Micro RNA profiling: an easy and rapid method to screen and characterize stem cell populations.

Methods Mol Biol 2007 ;407:97-114

Stem Cell Institute, University of Minnesota, Minneapolis, USA.

View Article
June 2008
2 Reads
7 Citations

Gene transfer via nucleofection into adult and embryonic stem cells.

Methods Mol Biol 2007 ;407:115-26

Stem Cell Institute, University of Minnesota, Minneapolis, USA.

View Article
June 2008
1 Read
3 Citations

Concise review: MicroRNA expression in multipotent mesenchymal stromal cells.

Stem Cells 2008 Feb 8;26(2):356-63. Epub 2007 Nov 8.

Stem Cells and Regenerative Medicine, Invitrogen Corporation, 1600 Faraday Avenue, Carlsbad, California 92008, USA.

View Article
February 2008
1 Read
35 Citations
6.520 Impact Factor

Creation of engineered human embryonic stem cell lines using phiC31 integrase.

Stem Cells 2008 Jan 25;26(1):119-26. Epub 2007 Oct 25.

Invitrogen Corporation, Carlsbad, California 92008, USA.

View Article
January 2008
21 Reads
28 Citations
6.520 Impact Factor

MicroRNA expression pattern of undifferentiated and differentiated human embryonic stem cells.

Stem Cells Dev 2007 Dec;16(6):1003-16

Invitrogen Corporation, Carlsbad, CA 92008, USA.

View Article
December 2007
1 Read
59 Citations
3.730 Impact Factor

Efficient transfection of embryonic and adult stem cells.

Stem Cells 2004 ;22(4):531-43

Stem Cell Institute, Hematology, Oncology and Transplantation Division, University of Minnesota, Minneapolis 55455, USA.

View Article
March 2005
17 Reads
36 Citations
6.520 Impact Factor

Stem cell plasticity.

Blood Rev 2005 Jan;19(1):29-38

Stem Cell Institute, Hematology, Oncology and Transplantation Division, Department of Medicine, University of Minnesota, 420 Delaware Street, Minneapolis, MN 55455, USA.

View Article
January 2005
3 Reads
26 Citations
5.570 Impact Factor

Expression of bacterial endonucleases in Saccharomyces cerevisiae mitochondria.

Mitochondrion 2002 Nov;2(1-2):47-57

Department of Pharmacology, University of Minnesota Medical School, 6-120 Jackson Hall, 321 Church Street, SE, Minneapolis, MN 55455, USA.

View Article
November 2002
5 Reads
3.250 Impact Factor